
Wednesday, May 25, 2022 3:45:08 PM
Canndoc Logo
In June 2020, Organigram entered into a multi-year agreement to supply dried flowers to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (TASE: INCR/INCR.TA).
Canndoc has been a pioneer in pharmaceutical-grade cannabis for more than 12 years. Its GMP-approved medical cannabis products are sold in pharmacies in Israel, and it holds international cultivation and distribution agreements in the European Union and Canada.
Under the terms of Organigram’s supply agreement with Canndoc (the “Agreement”), the Company will provide a guaranteed 3,000 kg of high quality, indoor-grown dried flower product to Canndoc by December 31, 2021, for processing and distribution into the Israeli medical market, and may provide an additional 3,000 kg during the same time period at Canndoc’s option, subject to certain conditions. The agreement provides for a tiered pricing scheme and the exact value will vary depending on factors such as potency and product mix. The Agreement also contemplates, among other things, an opportunity for Organigram to launch branded medical products with Canndoc in the Israeli and EU markets, and grants exclusivity and related rights to Canndoc within the Israel market for a period of approximately 7.5 years. Activities under the Agreement are subject to compliance with all applicable laws, including receipt of all requisite approvals from Health Canada, the Israeli Ministry of Health, and any other applicable regulatory authorities.

Liked By
Spread the love. Be the first to like this post!
Recent OGI News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/26/2023 04:18:49 PM
- Organigram Provides NASDAQ Listing Update • Business Wire • 01/26/2023 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/12/2023 12:47:58 PM
- Organigram Reports Record First Quarter Fiscal 2023 Results • Business Wire • 01/12/2023 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/05/2023 02:53:51 PM
- Organigram to Report First Quarter Fiscal 2023 Results on January 12, 2023 • Business Wire • 01/05/2023 11:00:00 AM
- Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl) • Edgar (US Regulatory) • 12/19/2022 04:25:43 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/09/2022 02:54:27 PM
- Organigram Wins KIND Magazine’s Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS • Business Wire • 12/08/2022 11:00:00 AM
- Three Reasons It’s Time To Get Bullish On Organigram • ValueWalk • 11/29/2022 11:51:33 PM
- Organigram Reports Record Fourth Quarter and Full Year Fiscal 2022 Results • Business Wire • 11/29/2022 01:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/23/2022 06:28:57 PM
- Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories • Business Wire • 11/23/2022 11:00:00 AM
- High Tide Becomes Top Revenue-Generating Cannabis Company in Canada • PR Newswire (US) • 11/22/2022 11:00:00 AM
- High Tide Becomes Top Revenue-Generating Cannabis Company in Canada • PR Newswire (Canada) • 11/22/2022 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/18/2022 01:22:51 PM
- Organigram to Report Annual Fiscal 2022 Results on November 28, 2022 • Business Wire • 11/18/2022 01:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/17/2022 06:45:02 PM
- Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies • GlobeNewswire Inc. • 11/17/2022 01:17:09 PM
- Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies • Business Wire • 11/17/2022 01:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 07/14/2022 04:23:01 PM
- Organigram Reports Third Quarter Fiscal 2022 Results • Business Wire • 07/14/2022 10:00:00 AM
- Organigram to Report Third Quarter 2022 Results on July 14, 2022 • Business Wire • 07/09/2022 12:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/24/2022 05:42:09 PM
- Proposed Settlement Reached in 2016 Class Action • Business Wire • 06/24/2022 12:00:00 AM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM